These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 10999097

  • 1. Appraising the power of placebo.
    Lal A, Moharana AK, Singh J.
    J Assoc Physicians India; 1999 Feb; 47(2):224-9. PubMed ID: 10999097
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Are placebo-controlled trials still important for obsessive compulsive disorder?
    Fineberg NA, Hawley CJ, Gale TM.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):413-22. PubMed ID: 16413647
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The nature and power of the placebo effect.
    Miller FG, Rosenstein DL.
    J Clin Epidemiol; 2006 Apr; 59(4):331-5. PubMed ID: 16549251
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Much ado about nothing.
    Ader R.
    Adv Mind Body Med; 2001 Apr; 17(4):293-5; discussion 312-8. PubMed ID: 11931053
    [No Abstract] [Full Text] [Related]

  • 8. Placebo misconceptions.
    Senn S.
    Am J Bioeth; 2009 Sep; 9(9):53-4. PubMed ID: 19998195
    [No Abstract] [Full Text] [Related]

  • 9. The placebo effect: why we should care.
    Tausk F, Ader R, Duffy Smith N.
    Clin Dermatol; 2013 Sep; 31(1):86-91. PubMed ID: 23245979
    [Abstract] [Full Text] [Related]

  • 10. The placebo efficacy study: problems with the definition of the placebo and the mechanisms of placebo efficacy.
    Wickramasekera I.
    Adv Mind Body Med; 2001 Sep; 17(4):309-12; discussion 312-8. PubMed ID: 11931057
    [No Abstract] [Full Text] [Related]

  • 11. Placebos: our most effective therapy?
    Holbrook A, Goldsmith C.
    Can J Clin Pharmacol; 2004 Sep; 11(1):e39-40. PubMed ID: 15226525
    [Abstract] [Full Text] [Related]

  • 12. The placebo enigma.
    Pearce JM.
    QJM; 1995 Mar; 88(3):215-20. PubMed ID: 7767672
    [No Abstract] [Full Text] [Related]

  • 13. Who controls the placebo? Introducing a Placebo Quality Checklist for pharmacological trials.
    Brinkhaus B, Pach D, Lüdtke R, Willich SN.
    Contemp Clin Trials; 2008 Mar; 29(2):149-56. PubMed ID: 17669693
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Drug-placebo difference: in antidepressant drug trials could be 50% greater than previously believed.
    Rihmer Z.
    Neuropsychopharmacol Hung; 2007 Mar; 9(1):35-7. PubMed ID: 17879563
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The mousetrap: managing the placebo effect in antidepressant trials.
    Lakoff A.
    Mol Interv; 2002 Apr; 2(2):72-6. PubMed ID: 14993352
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.